Biocompatibility and antibacterial activity of strontium and silver ion-releasing titanium with high silver treatment concentration
To overcome problems associated with surgical site infection and implant loosening, we developed a titanium (Ti)-based material employing a modified alkaline heat treatment that releases strontium (Sr) and silver (Ag) ions (CaSrAg-Ti). In this study, to determine the optimal Ag treatment concentration, we prepared four different materials-commercially pure Ti (cp-Ti) as a negative control, CaSr1mMAg-Ti, CaSr10mMAg-Ti, and CaSr50mMAg-Ti. Ion release test was performed by immersing the prepared disks in fetal bovine serum. With increased loading of Ag ions, the amount of released ions increased. Colony-forming unit count assay was performed using methicillin-susceptible <i>Staphylococcus aureus</i> and <i>Escherichia coli</i>. High antibacterial activity was observed in CaSr10mMAg-Ti and CaSr50mMAg-Ti groups. <i>In vivo</i> experiments were performed using the rat subcutaneous pocket infection model and evaluated by counting the attached bacteria, wound appearance, and histological evaluation. High antibacterial activity value (AAV >2) and anti-inflammatory effects were observed in the CaSr50mMAg-Ti group. However, CaSr10mMAg-Ti did not exhibit consistent antibacterial activity. For <i>in vivo</i> biocompatibility and bone-bonding ability evaluation, rods were implanted into the rat femur. No cytotoxicity was observed at 1 week, and good bone-bonding ability at 4 and 8 weeks was not significantly different from that of CaSr1mMAg-Ti. To evaluate <i>in vivo</i> bioactivity and cytotoxicity, MC3T3-E1 cells were cultured on disks. CaSr10mMAg-Ti and CaSr50mMAg-Ti significantly inhibited the proliferation and differentiation of MC3T3E1 cells, as well as the production of extracellular matrix <i>in vivo</i>, despite showing good biocompatibility <i>in vivo</i>. In conclusion, CaSr50mMAg-Ti, with increased Ag ion loading, exhibited high antibacterial activity <i>in vivo</i> while maintaining the bone-bonding ability and is a promising therapeutic biomaterial. Further research is needed to determine the optimal combination of therapeutic concentrations of Sr and Ag.
Authors
- Seiji Yamaguchi (ORCID: https://orcid.org/0000-0003-3467-4487)
- Yaichiro Okuzu
- Shunsuke Fujibayashi (ORCID: https://orcid.org/0000-0003-0662-4298)
- Norimasa Ikeda (ORCID: https://orcid.org/0000-0002-3191-3756)
- Bungo Otsuki (ORCID: https://orcid.org/0000-0002-4749-7830)
- Koji Goto (ORCID: https://orcid.org/0000-0002-8174-5391)
- Toshiyuki Kawai (ORCID: https://orcid.org/0000-0003-3988-6411)
- K Orita (ORCID: https://orcid.org/0000-0002-2557-6183)
- Yusuke Takaoka (ORCID: https://orcid.org/0000-0002-0886-7763)
- Shintaro Honda (ORCID: https://orcid.org/0000-0001-9387-7730)
- Takayoshi Shimizu (ORCID: https://orcid.org/0000-0002-2683-0489)
- Tatsuhito Ikezaki
- Makoto Hayashi (ORCID: https://orcid.org/0000-0003-4337-7361)
- Shuichi Matsuda (ORCID: https://orcid.org/0000-0003-0802-1255)
Institutions
- Chubu University (JP)
- Kyoto University (JP)
- Kindai University Hospital (JP)
Publication Details
- Journal
- Journal of Biomaterials Applications
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1177/08853282251329276
- Primary Topic
- Orthopaedic implants and arthroplasty
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science